Medicamen Biotech Limited (MEDICAMEQ) — Working Capital to Net Assets Ratio
Medicamen Biotech Limited (MEDICAMEQ) has a Working Capital to Net Assets ratio of 50.0% as of September 2025. Working capital of Rs1.38 Billion (current assets of Rs2.23 Billion minus current liabilities of Rs855.86 Million) is measured against net assets of Rs2.75 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See MEDICAMEQ free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Medicamen Biotech Limited Working Capital to Net Assets (2006–2025)
This chart shows how Medicamen Biotech Limited's Working Capital to Net Assets ratio has evolved across 20 annual periods from 2006 to 2025. As of September 2025, the ratio stands at 50.0%, reflecting working capital of Rs1.38 Billion against net assets of Rs2.75 Billion INR. See defensive interval ratio of Medicamen Biotech Limited to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Medicamen Biotech Limited (2006–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Medicamen Biotech Limited from 2006 to 2025, covering 20 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see MEDICAMEQ stock market capitalisation.
| Year | WC/NA Ratio | Working Capital (INR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 40.6% | Rs863.84 Million | Rs2.13 Billion | Rs1.65 Billion | Rs781.65 Million | ▲ +4.3 pp |
| 2024 | 36.3% | Rs750.38 Million | Rs2.07 Billion | Rs1.60 Billion | Rs845.55 Million | ▼ -5.5 pp |
| 2023 | 41.8% | Rs807.89 Million | Rs1.93 Billion | Rs1.63 Billion | Rs825.74 Million | ▲ +7.4 pp |
| 2022 | 34.4% | Rs503.47 Million | Rs1.46 Billion | Rs1.23 Billion | Rs726.91 Million | ▲ +2.2 pp |
| 2021 | 32.2% | Rs427.59 Million | Rs1.33 Billion | Rs960.33 Million | Rs532.74 Million | ▼ -7.1 pp |
| 2020 | 39.3% | Rs476.48 Million | Rs1.21 Billion | Rs1.04 Billion | Rs564.84 Million | ▼ -15.7 pp |
| 2019 | 55.0% | Rs476.25 Million | Rs866.34 Million | Rs961.68 Million | Rs485.44 Million | ▼ -11.7 pp |
| 2018 | 66.7% | Rs497.78 Million | Rs746.08 Million | Rs909.86 Million | Rs412.08 Million | ▲ +26.7 pp |
| 2017 | 40.0% | Rs107.14 Million | Rs267.81 Million | Rs533.80 Million | Rs426.67 Million | ▲ +21.3 pp |
| 2016 | 18.7% | Rs33.52 Million | Rs179.09 Million | Rs405.95 Million | Rs372.43 Million | ▼ -3.2 pp |
| 2015 | 21.9% | Rs37.66 Million | Rs171.85 Million | Rs485.08 Million | Rs447.43 Million | ▲ +44.0 pp |
| 2014 | -22.1% | Rs-36.59 Million | Rs165.38 Million | Rs419.48 Million | Rs456.07 Million | ▲ +14.9 pp |
| 2013 | -37.0% | Rs-58.21 Million | Rs157.17 Million | Rs419.09 Million | Rs477.31 Million | ▼ -28.0 pp |
| 2012 | -9.0% | Rs-18.13 Million | Rs201.01 Million | Rs453.02 Million | Rs471.15 Million | ▼ -47.0 pp |
| 2011 | 38.0% | Rs77.62 Million | Rs204.12 Million | Rs468.25 Million | Rs390.63 Million | ▼ -16.1 pp |
| 2010 | 54.2% | Rs88.07 Million | Rs162.61 Million | Rs370.11 Million | Rs282.03 Million | ▲ +24.5 pp |
| 2009 | 29.7% | Rs38.45 Million | Rs129.60 Million | Rs274.93 Million | Rs236.47 Million | ▲ +41.9 pp |
| 2008 | -12.3% | Rs-14.19 Million | Rs115.83 Million | Rs343.47 Million | Rs357.67 Million | ▼ -13.0 pp |
| 2007 | 0.8% | Rs790.00K | Rs100.73 Million | Rs312.80 Million | Rs312.01 Million | ▼ -27.3 pp |
| 2006 | 28.1% | Rs24.04 Million | Rs85.67 Million | Rs230.54 Million | Rs206.49 Million | — |